These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15384962)

  • 1. Release of endothelium-associated proteins into blood by injection of heparin in normal subjects and in patients with Type 1 diabetes.
    Myrup B; Yokoyama H; Kristiansen OP; Østergaard PB; Olivecrona T
    Diabet Med; 2004 Oct; 21(10):1135-40. PubMed ID: 15384962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients.
    Lee SJ; Choi MG; Kim DS; Kim TW
    Metabolism; 2006 Jan; 55(1):1-7. PubMed ID: 16324912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased renal glucose metabolism in Type 1 diabetes mellitus.
    Meyer C; Tolias A; Platanisiotis D; Stumvoll M; Vlachos L; Mitrakou A
    Diabet Med; 2005 Apr; 22(4):453-9. PubMed ID: 15787672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
    Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
    Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy].
    Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Cheng YS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):729-31. PubMed ID: 15958323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
    Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
    Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
    De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
    Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
    Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy].
    Shestakova MV; Chugunova LA; Vorontsov AV; Dedov II
    Ter Arkh; 1997; 69(6):34-7. PubMed ID: 9297270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy.
    Möllsten A; Marklund SL; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Diabetes; 2007 Jan; 56(1):265-9. PubMed ID: 17192491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
    Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
    Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
    Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotective effect of N-type Ca channel blockade in diabetic nephropathy.
    Fujisawa T; Ikegami H; Noso S; Hiromine Y; Kawabata Y; Nishino M; Asano K; Ogihara T
    J Diabetes Complications; 2007; 21(4):252-7. PubMed ID: 17616356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.